Free Trial
OTCMKTS:LTUS

Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Lotus Pharmaceuticals logo
$0.0052 0.00 (-38.82%)
As of 09/5/2025 12:45 PM Eastern

About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)

Key Stats

Today's Range
$0.0046
$0.0059
50-Day Range
$0.0044
$0.0111
52-Week Range
$0.0006
$0.0111
Volume
246,000 shs
Average Volume
2,654 shs
Market Capitalization
$13.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LTUS Stock News Headlines

Elon + Nvidia Teaming Up?
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.tc pixel
Lotus Pharmaceutical Co Ltd (1795) - Investing.com UK
Lotus Pharmaceuticals Inc Price / Book
See More Headlines

LTUS Stock Analysis - Frequently Asked Questions

Lotus Pharmaceuticals' stock was trading at $0.0060 on January 1st, 2025. Since then, LTUS stock has decreased by 13.3% and is now trading at $0.0052.

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

Today
9/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:LTUS
CIK
N/A
Employees
230
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,644,520,000
Free Float
N/A
Market Cap
$13.75 million
Optionable
Not Optionable
Beta
-2.34

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:LTUS) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners